Cargando…
Therapeutic effects of fibroblast growth factor-21 against atherosclerosis via the NF-κB pathway
Fibroblast growth factor-21 (FGF-21) is a pleiotropic protein predominantly secreted in the liver, adipose tissue and pancreas. It has been reported that the metabolic hormone effects of FGF-21 on energy metabolism are essential for human vascular endothelial cells. The aim of the present study was...
Autores principales: | Zhang, Yiming, Liu, Zhao, Zhou, Min, Liu, Changjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780083/ https://www.ncbi.nlm.nih.gov/pubmed/29257234 http://dx.doi.org/10.3892/mmr.2017.8100 |
Ejemplares similares
-
Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
por: Jin, Leigang, et al.
Publicado: (2016) -
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
por: Kwok, Kelvin H. M., et al.
Publicado: (2017) -
Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR(−/−) Mice
por: Zhang, Yifan, et al.
Publicado: (2022) -
STAT3/NF-κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF-κB signaling pathway in a mouse model of atherosclerosis
por: An, Hyun-Jin, et al.
Publicado: (2023) -
Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits
por: Huang, Ying, et al.
Publicado: (2018)